John JJson Johnson
Pharma

J&J charts speedy launch of new psoriasis pill Icotyde

Protagonist Therapeutics-partnered Icotyde has the potential to become one of Johnson & Johnson's "largest products ever," CEO Joaquin Duato said.
Zoey Becker Apr 14, 2026 11:43am
Human kidney anatomy

In another win for rare disease, Travere nabs FDA’s first FSGS nod

Apr 13, 2026 6:25pm
long road journey highway desert mountains path

Travere charts blockbuster path for Filspari after key approval

Apr 14, 2026 7:05pm
Lilly

Lilly told to gather more safety info on obesity launch Foundayo

Apr 14, 2026 4:08pm
Molecular structure in shape of AI

Novo becomes latest drugmaker to strike OpenAI pact

Apr 14, 2026 10:13am
Facebook logo data sharing

Pfizer rebuked by FDA for misleading Adcetris ads on Facebook

Apr 14, 2026 4:22am
More News

Regulatory tracker: FDA approves generics for AZ's Farxiga

Apr 13, 2026 10:45am

Lilly touts Jaypirca fixed-duration win in ‘ambitious’ CLL trial

Apr 13, 2026 10:16am
Fierce Biotech

Regeneron rides into radiopharma via $2.1B biobucks Telix pact

Apr 13, 2026 7:24am

HHS updates ACIP charter with new emphasis on vaccine safety

Apr 10, 2026 4:06pm